Shimadzu upgrades CT and MRI platforms
Shimadzu Medical Systems has been busy since last year's RSNAmeeting upgrading CT and MRI scanners it introduced at that show.In MRI, the Torrance, CA, company will unveil three new models:Magnex Alpha II, Magnex 100/AP and Magnex 100/XP. Magnex Alpha II
Shimadzu Medical Systems has been busy since last year's RSNAmeeting upgrading CT and MRI scanners it introduced at that show.In MRI, the Torrance, CA, company will unveil three new models:Magnex Alpha II, Magnex 100/AP and Magnex 100/XP.
Magnex Alpha II is a 0.5-tesla scanner that improves on lastyear's Alpha platform with 14 millitesla/meter gradients, comparedto 10 mtesla/m gradients on Alpha. Magnex 100/AP and Magnex 100/XPare 1-tesla scanners. Magnex 100/XP is the more fully featuredmodel, with 15 mtesla/m gradients capable of one-second T2-weightedimaging. Both models have redesigned consoles that are similarto those of the Alpha line.
In CT, Shimadzu will again show the SCT-7000TX and SCT-7000THscanners, the vendor's first slip-ring scanners, which were introducedlast year.
In vascular imaging, Shimadzu will display new digital imagingcapabilities for the MH-100 ceiling-suspended C-arm, such as real-timesmooth mask (RSM), a work-in-progress technique in which the C-armmoves in a circular tomographic-style motion and acquires digitalsubtraction angiography (DSA) images at the same time.
Seven Takeaways from Meta-Analysis of PSMA Radiotracers for Prostate Cancer Imaging
December 1st 2023In a newly published meta-analysis of 24 studies, researchers noted that the PSMA PET radiotracer 18F PSMA-1007 may provide more benefit than 68Ga Ga-PSMA-11 for primary staging of patients with prostate cancer and detection of local lesion recurrence, but also has drawbacks with higher liver uptake and multiple reports of false positive bone lesions.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
Chest CT Study Shows Higher Emphysema Risk from Combination of Marijuana and Cigarette Smoking
November 28th 2023People who smoke marijuana and cigarettes have 12 times the risk for centrilobular emphysema than non-smokers, according to new computed tomography (CT) research presented at the annual Radiological Society of North America (RSNA) conference.
